Form 10-K for the Fiscal Year Ended December 31, 2022
Given the importance of research and development expenses to your business model and the multiple product candidates under development, please revise future filings to disclose total costs by product candidate as well as by the nature of expense for each period presented. To the extent that you do not track expenses by product candidate, please disclose as such.
to the Staff’s comment, the Company proposes to add in its future filings, beginning with the Form 10-Q for the quarter ended March 31, 2023, disclosure consistent with the proposed disclosure set forth on Annex A to this letter for as long as research and development expenses continue to represent a significant portion of the Company’s total expenses.Read in the replyRest of the answer
The Company anticipates that the proposed disclosure would be included in Part I, Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations under the caption “Results of Operations—Three Months Ended March 31, 2023 and 2022—Research and Development Expenses.”
First report after the company's reply of Apr 11, 2023: 10-Q filed May 8, 2023 ↗, against the 10-Q filed Nov 7, 2022 ↗.
Tickdelta does not hold the text of both reports, so they are not compared here.
Also in this review: closing letter, 2023-04-24